LearnGlossaryMarketStocksSuperinvestorsSign in

QDEL

QuidelOrtho Corporation

Healthcare · $746M market cap

Verdict

We can't put a fair value on QDEL right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

4 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth80.2% a year✓
Equity per share growth13.7% a year✓
Sales growth35.9% a year✓
Free cash flow growth20.2% a year✓
Return on invested capital-16.8%✗

Follow QDEL

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds QDEL right now. In Q1 2026, 1 sold out. Who we track

Moves in Q1 2026

Sold out: Lee Ainslie

About QuidelOrtho Corporation

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease…

Medical - Specialties

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works